Trademark: 98033730
Word
DEMOCRATIZING DRUG TESTING
Status
Dead
Status Code
602
Status Date
Thursday, May 9, 2024
Serial Number
98033730
Mark Type
4
Filing Date
Thursday, June 8, 2023
Abandoned Date
Monday, April 22, 2024

Trademark Owner History

Classifications
9 Downloadable software and downloadable mobile applications for use in connection with detecting, screening, and monitoring the presence of drugs; downloadable software and downloadable mobile applications for reporting test results to government agencies, insurers, employers, companies, and users; e-passports containing release codes for screening results; encoded bar code labels containing an array of black and white squares containing release codes for screening results; e-passports containing digital release codes for screening results; downloadable software and downloadable mobile applications for use in connection with providing medical and health related education and training; downloadable software and downloadable mobile applications for use in connection with data and information management, receipt, storage, display, tracking, sharing, management, monitoring, and analysis
5 Diagnostic preparations for medical purposes; test kits for diagnostic purposes, namely, medical diagnostic test strips for use in the field of the detection of drugs; rapid drug screening tests comprised of diagnostic and chemical reagents for the simultaneous, qualitative detection of multiple drugs and/or metabolites, for medical purposes
38 Audio teleconferencing; instant messaging services; network conferencing services; teleconferencing services; video conferencing services; video teleconferencing
36 Financial and business administration of health reimbursement arrangements and programs; Reimbursement payment processing in the field of insurance claims; Providing healthcare administration, namely, providing insurance verification and reimbursement payment processing services; Insurance services, namely, submitting claims for preauthorization in the healthcare industry
1 Diagnostic kits consisting primarily of reagents and antibodies to detect drugs for drug screening; rapid drug screening tests comprised of diagnostic and chemical reagents for the simultaneous, qualitative detection of multiple drugs and/or metabolites, not for medical purposes
45 Providing document and identity verification services, namely, providing remote identity document scanning being electronic scanning of personally identifying photographic images, photo scanning, digitization of documents, data extraction being data encryption, data decryption, authentication and verification services being providing a website; screening of individuals in the nature of personal identity verification services provided through digital technology to authenticate user identity
44 Provision of remote medical services, namely, assessing patient eligibility for medication and prescribing medication prescribing medication; drug use testing services; drug use screening services; medical services, namely, drug screening; telemedicine services, namely, providing remote proctoring of drug tests; verification of personal identity as part of personal background analysis; identity verification services; authentication of personal identifying information via secure storage and transmission of supporting evidence via the internet; authentication of personal identifying information via video conference; providing document and identity verification services, namely, providing remote identity document scanning being electronic scanning of personally identifying photographic images, photo scanning, digitization of documents, data extraction being data encryption, data decryption, authentication and verification services being providing a website; screening of individuals in the nature of personal identity verification services provided through digital technology to authenticate user identity
42 Providing on-line, non-downloadable internet-based software for use in detecting, screening and monitoring the presence of drugs; providing on-line, non-downloadable cloud-based software for use in detecting, screening and monitoring the presence of drugs; software as a service (SAAS) services featuring software for use in detecting, screening and monitoring the presence of drugs; platform as a service (PAAS) featuring software for detecting, screening, and monitoring the presence of drugs; providing on-line, non-downloadable internet-based software for use in connection with data and information management, receipt, storage, display, tracking, sharing, management, monitoring, and analysis; providing on-line, non-downloadable cloud-based software for use in connection with data and information management, receipt, storage, display, tracking, sharing, management, monitoring, and analysis; software as a service (SAAS) services featuring software for use in connection with data and information management, receipt, storage, display, tracking, sharing, management, monitoring, and analysis; platform as a service (PAAS) featuring software for use in connection with data and information management, receipt, storage, display, tracking, sharing, management, monitoring, and analysis; providing temporary use of on-line non-downloadable mobile applications for use in connection with detecting, screening, and monitoring the presence of drugs; providing temporary use of on-line non-downloadable mobile applications for use in conducting medical and health related education and training; providing temporary use of on-line non-downloadable mobile applications for use in connection with data and information management, receipt, storage, display, tracking, sharing, management, monitoring, and analysis; software as a service (SAAS) services featuring software for providing an online platform that enables video conferencing connectivity between proctors and users; software as a service (SAAS) services featuring software for live digital communications, namely, live video and audio conferencing with multiple simultaneous users, teleconferencing, and network conferencing; software as a service (SAAS) services featuring software for providing an online platform to enable workflow management of a proctored examination; software as a service (SAAS) services featuring software for providing an online platform to enable video conferencing connectivity between proctors and users to conduct a proctored test; platform as a service (PAAS) featuring computer software platforms for proctoring of exams; platform as a service (PAAS) featuring computer software platforms for providing online identity verification services and for creating identity verification reports; platform as a service (PAAS) featuring computer software platforms for providing process verification services for businesses and for creating process verification reports; cloud based software as a service (SAAS) services, comprising AI-enabled proctoring to ensure integrity of remote assessments with real-time image, audio, and video proctoring, assessing functional, programming, technical and communication skills in real-time with video interviews, preventing cheating using AI, and conducting video interviews; software as a service (SAAS) services featuring software for secure exam proctoring and content protection, identification verification, and data analytics associated therewith; software as a service (SAAS) services featuring software for providing proctored examination testing, examination monitoring, and for reporting examination and testing results to government agencies, insurers, employers, companies, and users; providing temporary use of on-line non-downloadable cloud-based computer software for autonomous online proctoring and identity verification; providing temporary use of online non-downloadable software for enabling video conferencing connectivity between proctors and users; software as a service (SAAS) services featuring software for providing an online platform that enables users to order diagnostic tests, to take diagnostic tests online with the guidance of a proctor, to view and access test results, and to order pharmaceuticals and prescriptions; software as a service (SAAS) services featuring software for providing an online platform that enables AI-based guidance through self-administered diagnostic tests; software as a service (SAAS) services featuring software for providing an online platform that enables users to access digital health results

Trademark Events
Jun 12, 2023
New Application Entered
Jul 12, 2023
New Application Office Supplied Data Entered
Jan 8, 2024
Assigned To Examiner
Jan 19, 2024
Non-Final Action E-Mailed
Jan 19, 2024
Non-Final Action Written
Jan 19, 2024
Notification Of Non-Final Action E-Mailed
May 9, 2024
Abandonment Notice E-Mailed - Failure To Respond
May 9, 2024
Abandonment - Failure To Respond Or Late Response

Trademark Alertz updated from USPTO on 2030-01-24